Breast Cancer, Clinical Trials and the Black Community

Increasing clinical trial participation from people of color is crucial because it allows researchers to better understand how diseases and treatments affect diverse populations, leading to more accurate and effective treatments for everyone, ultimately helping to close the gap on health disparities by ensuring that medical advancements are relevant to the wider population, not just one demographic group.

Understanding how different populations respond to treatments can lead to more targeted therapies and treatment regimens designed to address specific needs. Engaging people of color in clinical trials is critical for advancing medical knowledge, ensuring equitable access to effective treatments, and ultimately reducing health disparities across diverse populations.

CBHN greatly appreciates the support of Eisai, a leading global research and development-based pharmaceutical company, Eisai conducts drug discovery and research activities by applying cutting-edge knowledge and technologies to various disease areas.

Please join the webinar discussion to hear from panel speakers: Marisa Hall- two-time breast cancer survivor Christina Carr-VanDunk – 14-year pancreatic cancer survivor. They will be sharing their stories on participating in clinical trials and how it positively impacted their lives and improved health outcomes.